22 results
DEFA14A
CRNX
Crinetics Pharmaceuticals Inc
25 Apr 24
Additional proxy soliciting materials
4:48pm
, you must request one. There is no charge to you for requesting a copy. In order to receive a paper package in time for this year's meeting, you must
8-K
EX-1.1
CRNX
Crinetics Pharmaceuticals Inc
13 Sep 23
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
5:23pm
prepared the following information (collectively with the pricing information set forth on Annex A, the “Pricing Disclosure Package”): a Preliminary … to offer the Shares on the terms set forth in the Pricing Disclosure Package. The Company acknowledges and agrees that the Underwriters may offer
DEFA14A
CRNX
Crinetics Pharmaceuticals Inc
27 Apr 23
Additional proxy soliciting materials
4:56pm
or e-mail copy of the proxy material, you must request one. There is no charge to you for requesting a copy. In order to receive a paper package in time
8-K
EX-99.1
r6zqqh qut
25 May 22
Regulation FD Disclosure
7:02am
DEFA14A
zyzh1q2e6 91
28 Apr 22
Additional proxy soliciting materials
4:58pm
8-K
EX-1.1
hth6yh7ihjnqrs 67
13 Apr 22
Crinetics Pharmaceuticals Announces Pricing of Underwritten Common Stock Offering
4:26pm
8-K
EX-99.2
en1j9j2
30 Mar 22
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results
4:05pm
8-K
EX-1.1
cfl1no517yt9k bydjp
21 Oct 21
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:24pm
DEFA14A
s6im8pnp
30 Apr 21
Additional proxy soliciting materials
12:00am
8-K
EX-1.1
oig7454oi7b
8 Apr 21
Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
4:09pm
DEFA14A
ki9j5v3ktf34p5
28 Apr 20
Additional proxy soliciting materials
4:10pm
8-K
EX-1.1
ryh5u4stvcfrigchz
15 Apr 20
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:06pm
DEFA14A
qaagtfy32wnp0l
29 Apr 19
Additional proxy soliciting materials
4:12pm